RING - Rituximab for Lupus Nephritis With Remission as a Goal

Summary

OBJECTIVE To test whether Rituximab (RTX) is efficacious to achieve complete renal response (CR) in Lupus Nephritis (LN) patients with persistent proteinuria (≥1g/d) despite at least 6 months of standard of care (SOC). STUDY DESIGN Investigator-initiated randomized international open multicentric 104-week study.

Timeline

Start

2014-11

Primary completion

2015-11

Completion

2016-11

Drugs

Indications